Axsome Therapeutics (AXSM) Misses Q1 EPS by 43c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($1.26), $0.43 worse than the analyst estimate of ($0.83). Revenue for the quarter came in at $191.2 million versus the consensus estimate of $193.46 million.

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• SK Hynix (SKHY) call put ratio 1.1 calls to 1 put as share price up 2.6%
• Market Vectors Semiconductor ETF (SMH) call put ratio 1 call to 1.7 puts as share price up 1%